Long‐Sheng Lu

3.9k total citations · 1 hit paper
66 papers, 2.9k citations indexed

About

Long‐Sheng Lu is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Long‐Sheng Lu has authored 66 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Oncology and 18 papers in Biomedical Engineering. Recurrent topics in Long‐Sheng Lu's work include Cancer Cells and Metastasis (9 papers), 3D Printing in Biomedical Research (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Long‐Sheng Lu is often cited by papers focused on Cancer Cells and Metastasis (9 papers), 3D Printing in Biomedical Research (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Long‐Sheng Lu collaborates with scholars based in Taiwan, China and United States. Long‐Sheng Lu's co-authors include Edward T.H. Yeh, Tasneem Bawa‐Khalfe, Yi Lisa Lyu, Xiaobing Liu, Sui Zhang, Leroy F. Liu, Jerry Ying Hsi Fuh, Y. S. Wong, Li‐Man Hung and Thang Van Nguyen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Long‐Sheng Lu

62 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

2012 1.4k citations Long‐Sheng Lu, Edward T.H. Yeh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Long‐Sheng Lu Taiwan	24	1.2k	1.0k	858	285	279	66	2.9k
Antonio Curcio Italy	31	1.2k 1.0×	1.2k 1.2×	264 0.3×	395 1.4×	158 0.6×	107	2.9k
Guosheng Fu China	35	1.8k 1.5×	1.5k 1.5×	253 0.3×	493 1.7×	634 2.3×	286	5.0k
Tomoki Nakamura Japan	29	485 0.4×	721 0.7×	1.0k 1.2×	1.3k 4.7×	267 1.0×	217	3.3k
Mohammad F. Kiani United States	36	335 0.3×	1.1k 1.1×	417 0.5×	537 1.9×	837 3.0×	110	3.6k
Lawrence W. Dobrucki United States	36	852 0.7×	1.5k 1.5×	400 0.5×	402 1.4×	1.2k 4.4×	116	4.5k
Zheyong Huang China	30	453 0.4×	1.2k 1.2×	208 0.2×	168 0.6×	479 1.7×	99	2.9k
Wen Jin Wu United States	26	355 0.3×	1.2k 1.2×	760 0.9×	133 0.5×	70 0.3×	62	2.3k
Guoqing Du China	28	160 0.1×	897 0.9×	764 0.9×	157 0.6×	294 1.1×	90	2.7k
Zijian Li China	29	491 0.4×	1.2k 1.2×	198 0.2×	145 0.5×	386 1.4×	117	3.9k
Joshua D. Hutcheson United States	32	1.1k 0.9×	1.1k 1.1×	121 0.1×	724 2.5×	388 1.4×	86	3.4k

Countries citing papers authored by Long‐Sheng Lu

Since Specialization

Citations

This map shows the geographic impact of Long‐Sheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long‐Sheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long‐Sheng Lu more than expected).

Fields of papers citing papers by Long‐Sheng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long‐Sheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long‐Sheng Lu. The network helps show where Long‐Sheng Lu may publish in the future.

Co-authorship network of co-authors of Long‐Sheng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Long‐Sheng Lu. A scholar is included among the top collaborators of Long‐Sheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long‐Sheng Lu. Long‐Sheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Long‐Sheng, Yuchen Ma, Qing Tao, et al.. (2025). Hypoxia-inducible factor-1 alpha (HIF-1α) inhibitor AMSP-30 m attenuates CCl4-induced liver fibrosis in mice by inhibiting the sonic hedgehog pathway. Chemico-Biological Interactions. 413. 111480–111480.

Fei, Chenghao, et al.. (2025). Enhanced therapeutic efficacy of Eupolyphaga sinensis Walker in females through sex-specific metabolomic-pharmacodynamic divergence. Scientific Reports. 15(1). 6032–6032.

Wu, Hongyan, et al.. (2025). Role of Neoadjuvant Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma—A Systematic Review and Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics. 122(5). 1257–1271. 1 indexed citations

Chang, Cheng‐Jen, et al.. (2024). Exploring the biphasic dose-response effects of photobiomodulation on the viability, migration, and extracellular vesicle secretion of human adipose mesenchymal stem cells. Journal of Photochemistry and Photobiology B Biology. 256. 112940–112940. 13 indexed citations

Zhao, Yingying, Jiali Qian, Hanxing Tong, et al.. (2024). TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway. Cellular Oncology. 48(2). 455–470. 1 indexed citations

Wu, Yuan‐Hung, Heng‐Sheng Chao, Chi‐Lu Chiang, et al.. (2023). Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids. Thoracic Cancer. 14(25). 2591–2600. 4 indexed citations

Liu, Yen‐Lin, Yin‐Ju Chen, Shu‐Huey Chen, et al.. (2023). Abstract 6723: Application of in vitro drug screening of circulating tumor cells in pediatric glioma therapy. Cancer Research. 83(7_Supplement). 6723–6723. 1 indexed citations

Burnouf, Thierry, Shu‐Huey Chen, Yin‐Ju Chen, et al.. (2023). Treatment response prediction with circulating tumor cell-derived organoids for soft tissue sarcoma.. Journal of Clinical Oncology. 41(16_suppl). e23521–e23521. 2 indexed citations

Mutalik, Chinmaya, et al.. (2022). Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy. Nanomaterials. 12(17). 2948–2948. 21 indexed citations

10.

Hsu, Fang‐Chi, Hsin‐Lun Lee, Yin‐Ju Chen, et al.. (2022). A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions. Cancers. 14(2). 445–445. 7 indexed citations

11.

Lin, Kuan‐Chou, Lai‐Lei Ting, Chia‐Lun Chang, et al.. (2021). Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer. Cancers. 13(23). 6076–6076. 31 indexed citations

12.

Malwade, Shwetambara, Long‐Sheng Lu, Lung‐Wen Tsai, et al.. (2021). Deep-Learning Approach to Predict Survival Outcomes Using Wearable Actigraphy Device Among End-Stage Cancer Patients. Frontiers in Public Health. 9. 730150–730150. 16 indexed citations

13.

Chang, Hua‐Ching, et al.. (2021). Activation of kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway by curcumin enhances the anti-oxidative capacity of corneal endothelial cells. Biomedicine & Pharmacotherapy. 141. 111834–111834. 20 indexed citations

14.

Lee, Hsin‐Lun, Jeng-Fong Chiou, Peng‐Yuan Wang, et al.. (2020). Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer. Cancers. 12(11). 3394–3394. 33 indexed citations

15.

Lee, Hsun‐Hua, Wei-Jiunn Lee, Yen‐Lin Chen, et al.. (2020). DNA polymerase theta repression enhances the docetaxel responsiveness in metastatic castration-resistant prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(12). 165954–165954. 8 indexed citations

16.

Burnouf, Thierry, Pierre‐Alain Burnouf, Yu‐Wen Wu, et al.. (2017). Circulatory-cell-mediated nanotherapeutic approaches in disease targeting. Drug Discovery Today. 23(5). 934–943. 28 indexed citations

17.

Chu, Chih‐Sheng, Long‐Sheng Lu, Brian Walton, et al.. (2013). Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor. PLoS ONE. 8(8). e70533–e70533. 41 indexed citations

18.

Nguyen, Thang Van, Pornpimon Angkasekwinai, Hong Dou, et al.. (2012). SUMO-Specific Protease 1 Is Critical for Early Lymphoid Development through Regulation of STAT5 Activation. Molecular Cell. 45(2). 210–221. 97 indexed citations

19.

Lu, Long‐Sheng, et al.. (2007). Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats. American Journal of Physiology-Heart and Circulatory Physiology. 293(2). H978–H987. 45 indexed citations

20.

Lu, Long‐Sheng, Yen‐Bin Liu, Chia-Wei Sun, et al.. (2006). Optical mapping of myocardial reactive oxygen species production throughout the reperfusion of global ischemia. Journal of Biomedical Optics. 11(2). 21012–21012. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact